Founded in 2016, Darwin Biotech is focused on transforming stem cell based therapy into cell-free, no exosomal, protein therapeutics. Leveraging proprietary technologies, we have successfully isolated and screened stem cell-derived components with exceptional neuro-restorative activity, and industrialized the production in manufacturing scale and clinical study standard. Our clinical breakthroughs in treating neurological injuries (e.g., stroke-induced damage) and neurodegenerative diseases (e.g. ALS and Alzheimer’s disease) have provided significant benefits for patients-in-need, and promises in engineering the future of neuro-restorative and regeneration medicine.